These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6171127)

  • 1. [Affinity of serum antibodies and splenocyte receptors in immunized CBA mice].
    Levi MI
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Sep; (9):96-102. PubMed ID: 6171127
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum antibody and splenocyte immunoglobulin receptor affinity in multiply immunized mice].
    Levi MI; Livshits MM
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):80-5. PubMed ID: 6895274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interleukin-1 induction by different antigens and strains of Yersinia pestis bacteria in immunized mice].
    Ledvanov MIu; Emel'ianova NV; Pronin AV; Drozdov IG; Brandzishevskiĭ IuV; Shvedun GP; Taranenko TM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):10-3. PubMed ID: 8067103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains.
    Sabhnani L; Manocha M; Tomar D; Shashikiran D; Rao DN
    Int Immunopharmacol; 2003 Oct; 3(10-11):1413-8. PubMed ID: 12946437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heterogeneity of monoclonal antibody affinity].
    Levi MI
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):67-74. PubMed ID: 3838847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of the antigens and strains of Yersinia pestis with the expression of different immunogenicity and virulence determinants on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):4-5. PubMed ID: 8553746
    [No Abstract]   [Full Text] [Related]  

  • 8. [An efficacy study of the immunization of white mice with plague anti-idiotypic antibodies].
    Devdariani ZL; Korolev BV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):85-7. PubMed ID: 8079589
    [No Abstract]   [Full Text] [Related]  

  • 9. [Patterns in the reactions between monovalent antigens and antibodies].
    Levi MI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Oct; (10):76-84. PubMed ID: 7192464
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isolation of high-affinity antibodies from hyperimmune serum].
    Levi MI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 May; (5):80-4. PubMed ID: 2476900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection.
    Hill J; Leary S; Smither S; Best A; Pettersson J; Forsberg A; Lingard B; Lipka A; Brown KA; Williamson ED; Titball RW
    Vaccine; 2009 Nov; 27(50):7073-9. PubMed ID: 19786138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the molecular weight of a soluble antigen on immunogenicity].
    Levi MI; Dalin MV; Nakoriakov VA; Livshits MM; Sakaian NN
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Dec; 50(12):77-83. PubMed ID: 4132082
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetic epitope mapping of monoclonal antibodies raised against the Yersinia pestis virulence factor LcrV.
    Read T; Olkhov RV; Williamson ED; Shaw AM
    Biosens Bioelectron; 2015 Mar; 65():47-53. PubMed ID: 25461137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.
    Li B; Jiang L; Song Q; Yang J; Chen Z; Guo Z; Zhou D; Du Z; Song Y; Wang J; Wang H; Yu S; Wang J; Yang R
    Infect Immun; 2005 Jun; 73(6):3734-9. PubMed ID: 15908403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant effect of anti-idiotypic antibodies to Yersinia pestis lipopolysaccharide.
    Feodorova VA; Devdariani ZL; Nazarova LS
    J Med Microbiol; 1999 Aug; 48(8):751-756. PubMed ID: 10450998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
    Khan AA; Babu JP; Gupta G; Rao DN
    Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Normal antibodies and immunologic reactivity].
    Levi MI; Selezneva TS; Livshits MM; Sakaian NN
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):81-7. PubMed ID: 986741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
    Uppada SB; Bhat AA; Sah A; Donthamshetty RN
    Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of antigenic determinants of Yersinia pestis lipopolysaccharide using monoclonal antibodies].
    Fedorova VA; Devdariani ZL
    Mol Gen Mikrobiol Virusol; 1998; (3):22-6. PubMed ID: 9819823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.